Trials / Not Yet Recruiting
Not Yet RecruitingNCT06691451
Inherited Thromophilia and Thrombotic Risks in Inflammatory Bowel Disease During Activity and Remission
Inherited Thrombophilia and Thrombotic Risks in Inflammatory Bowel Disease During Activity and Remission
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 93 (estimated)
- Sponsor
- Asmaa mohammed abdelaal abdelaal · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Inherited thombopllia and thrombotic risks in inflammatory bowel Disease during activity and remission
Detailed description
Inflammatory bowel diseases (IBD) are systemic conditions characterized by multiple intestinal and extra-intestinal manifestations related to the associated chronic inflammatory state. Among their diverse extra-intestinal complications, venous thromboembolism (VTE) remains one of the most under recognized causes of morbidity and mortality in these patients, highlighting the need for a better understanding of the underlying mechanism of hypercoagulability, in addition to the role of acquired and inherited risk factors that further increase the risk of thrombosis with its impact on patients' outcomes.\[1, 2\]
Conditions
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2026-12-01
- Completion
- 2027-03-01
- First posted
- 2024-11-15
- Last updated
- 2024-11-15
Source: ClinicalTrials.gov record NCT06691451. Inclusion in this directory is not an endorsement.